The American Society for Radiation Oncology (ASTRO) has updated its recommendations for using radiation therapy to treat patients with diagnosed pancreatic cancer.

CMS revealed details for their newly proposed alternative payment model for radiation oncology on July 10. The American Society of Radiation Oncology (ASTRO) believes the model, with adjustments, "will incentivize higher quality, more convenient radiation treatments for patients and support their journey toward a cure."

The American Society for Radiation Oncology (ASTRO) is championing bipartisan legislation introduced Wednesday, June 5, that would reduce prior authorization practices found to delay patient access to necessary cancer treatments.

“The results of this research are extremely exciting, as it will significantly impact clinical care,” reported study author Mishal Mendiratta-Lala, MD, with the division of abdominal radiology at Michigan Medicine in Ann Arbor.

Over the coming weeks, CMS will unveil a mandatory Medicare payment model for radiation oncology, Alex Azar, Health and Human Services secretary, said in a recent speech. The announcement drew a mixed reaction from the American Society of Radiation Oncology (ASTRO).

Stereotactic body radiation therapy (SBRT) is both safe and effective for men with low- and intermediate-risk prostate cancer, according to research presented Oct. 22 at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting.

Women with early-stage breast cancer who receive large doses of radiation once a week for five weeks will experience the same long-term side effects as women who undergo conventional radiation therapy, according to a ten-year study presented Oct. 21 at the 2018 American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio, Texas.

Contrary to recent data suggesting African-Americans face a higher mortality risk from prostate cancer than Caucasian men, a new study presented at the 2018 American Society for Radiation Oncology (ASTRO) Annual Meeting suggests African-American men may have higher cure rates when treated with radiation therapy than Caucasian men.